[Cognitive deficits in progressive supranuclear palsy]. 2003

Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
Klinika Neurologii Akademii Medycznej w Białymstoku. alakul@amb.ac.bialystok.pl

Progressive supranuclear palsy (PSP) is one of the most frequent causes of an atypical parkinsonism. The cognitive disturbances in PSP gave rise to the term "subcortical dementia". Cognitive impairment is independent of depression, which is also common in PSP. There is no correlation between cognitive impairment and either disease duration or a level of physical disability. We present a clinical picture and difficulties in PSP diagnosis in three patients--63 to 74 years old, who were hospitalized in the Department of Neurology, Medical Academy in Bialystok. A neuropsychological evaluation revealed significant differences among those patients. The patients presented with: 1. depressive and dementive syndrome, 2. executive dysfunction, 3. slowed information processing with no signs of dementia. Our findings are similar with data presented in literature and confirm the observations that: 1. there is a difference in a degree of cognitive impairment in between the patients with PSP, 2. the most frequent cognitive disturbances in PSP patients are: slowness of thought process and executive dysfunction.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson
D013494 Supranuclear Palsy, Progressive A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7) Ophthalmoplegia, Progressive Supranuclear,Progressive Supranuclear Ophthalmoplegia,Progressive Supranuclear Palsy 1,Steele-Richardson-Olszewski Syndrome,Palsy, Progressive Supranuclear,Progressive Supranuclear Palsy,Richardson's Syndrome,Steele-Richardson-Olszewski Disease,Supranuclear Palsy, Progressive, 1,Progressive Supranuclear Palsies,Richardson Syndrome,Steele Richardson Olszewski Disease,Steele Richardson Olszewski Syndrome,Supranuclear Ophthalmoplegia, Progressive,Supranuclear Palsies, Progressive

Related Publications

Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
December 1985, Journal of neurology, neurosurgery, and psychiatry,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
July 2012, Brain : a journal of neurology,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
January 1994, Journal of neural transmission. Supplementum,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
April 2020, Movement disorders : official journal of the Movement Disorder Society,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
January 1996, Advances in neurology,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
April 2023, Journal of neural transmission (Vienna, Austria : 1996),
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
March 2016, Journal of neuropsychology,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
September 1982, Archives of neurology,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
January 1971, Archiv fur Psychiatrie und Nervenkrankheiten,
Alina Kułakowska, and Elzbieta Pyd, and Dorota Halicka, and Robert Pogorzelski, and Wiesław Drozdowski
January 2003, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!